Long non-coding RNA SNHG5 promotes glioma progression via miR-205/E2F3 axis

Author:

Li Xiaojian1,Liu Liang1,Luo Yidan2,Cui Sitong1,Chen Wei1,Zeng Ailiang34,Shi Yan1,Luo Liangsheng1ORCID

Affiliation:

1. Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China

2. School of Pharmacy, Nanjing Medical University, Nanjing 211166, China

3. Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

4. Department of Neurology, Brigham and Women’s Hospital and Harvard Medical School, Boston 02115, MA, U.S.A.

Abstract

Abstract In recent years, many studies have reported on the abnormal expression and correlation of long non-coding RNAs (lncRNAs) in tumours. However, the accurate molecular mechanism of lncRNAs in glioma is still in its infancy. In the present study, we aimed to explore the molecular mechanism of small nucleolar RNA host gene 5 (SNHG5) in glioma progression. First, we found that SNHG5 expression was higher in glioma and was related to glioma glucose uptake, migration and invasion. Second, through a series of assays, we concluded that SNHG5 acts as a sponge for miR-205, which inhibits tumour growth in glioma by targeting E2F transcription factor 3 (E2F3). Third, using a xenograft mouse model, we demonstrated that SNHG5 regulates tumourigenesis in vivo. Taken together, our results show that the SNHG5/miR-205/E2F3 axis is involved in glioma progression and may provide a new therapeutic target for the diagnosis and therapy of glioma.

Publisher

Portland Press Ltd.

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference30 articles.

1. Long non-coding RNA GHET1 promotes viability, migration and invasion of glioma cell line U251 by down-regulation of miR-216a;Cao;Eur. Rev. Med. Pharmacol. Sci.,2019

2. Evidence-based practice: temozolomide beyond glioblastoma;Chua;Curr. Oncol. Rep.,2019

3. MicroRNA-1294 inhibits the proliferation and enhances the chemosensitivity of glioma to temozolomide via the direct targeting of TPX2;Chen;Am. J. Cancer Res.,2018

4. MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D;Liu;Am. J. Cancer Res.,2017

5. An overview on the management of cerebral glioma of highly eloquent areas;Javadi;J. Neurosurg. Sci.,2019

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3